FindTrial
Sign In

A study to identify the frequency and characteristics of patients with a bispectral index value of 60 or higher during induction and maintenance of general anesthesia with remimazolam

A study to identify the frequency and characteristics of patients with a bispectral index value of 60 or higher during induction and maintenance of general anesthesia with remimazolam

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007101
Enrollment
1500
Registered
2022-03-21
Start date
2022-04-11
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent general anesthesia in the operating rooms of Asan Medical Center from October 2021 to January 2022 2. Patients who underwent general anesthesia with remimazolam confirmed by dosing records on anesthesia record sheets

Exclusion criteria

Exclusion criteria: 1. Patients with anesthesia induction and maintenance with propofol or sevoflurane 2. Patients whose reasons for changing the hypnotic agent during induction and maintenance of anesthesia are not recorded on the anesthesia record sheet

Design outcomes

Primary

MeasureTime frame
Frequency of patients with a bispectral index value of 60 or higher during general anesthesia with remimazolam—

Secondary

MeasureTime frame
Whether there is a difference in physical characteristics between patients with well-maintained bispectral index below 60 and those who do not—

Countries

Korea, Republic of

Contacts

Public ContactByung-Moon Choi

Asan Medical Center

rios76@hanmail.net+82-2-3010-1704

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026